A detailed history of Virtu Financial LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 10,653 shares of AUPH stock, worth $85,756. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,653
Holding current value
$85,756
% of portfolio
0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$6.75 - $10.44 $71,907 - $111,217
10,653 New
10,653 $96,000
Q2 2024

Aug 09, 2024

BUY
$4.81 - $5.78 $185,237 - $222,593
38,511 Added 247.01%
54,102 $309,000
Q1 2024

May 20, 2024

BUY
$4.93 - $9.31 $76,863 - $145,152
15,591 New
15,591 $78,000
Q2 2023

Jul 27, 2023

BUY
$8.96 - $11.69 $141,523 - $184,643
15,795 New
15,795 $153,000
Q4 2022

Feb 15, 2023

BUY
$4.11 - $8.14 $126,888 - $251,306
30,873 New
30,873 $133,000
Q2 2022

Aug 09, 2022

BUY
$8.95 - $12.8 $7,204 - $10,304
805 Added 4.05%
20,658 $208,000
Q1 2022

May 17, 2022

BUY
$10.05 - $22.48 $199,522 - $446,295
19,853 New
19,853 $246,000
Q3 2021

Nov 12, 2021

SELL
$10.93 - $23.55 $733,654 - $1.58 Million
-67,123 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$10.0 - $14.52 $671,230 - $974,625
67,123 New
67,123 $870,000
Q2 2020

Aug 07, 2020

SELL
$14.12 - $18.33 $287,003 - $372,575
-20,326 Closed
0 $0
Q4 2019

Feb 04, 2020

SELL
$3.88 - $21.42 $9,552 - $52,736
-2,462 Reduced 10.8%
20,326 $412,000
Q3 2019

Nov 20, 2019

BUY
$5.34 - $6.59 $121,687 - $150,172
22,788 New
22,788 $122,000
Q1 2019

Apr 12, 2019

SELL
$6.06 - $7.64 $93,675 - $118,099
-15,458 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$5.08 - $6.83 $78,526 - $105,578
15,458 New
15,458 $105,000
Q2 2018

Jul 30, 2018

SELL
$5.06 - $6.36 $88,605 - $111,369
-17,511 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$5.06 - $6.36 $88,605 - $111,369
17,511 New
17,511 $99,000
Q4 2017

Feb 09, 2018

SELL
$4.53 - $7.09 $167,650 - $262,393
-37,009 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$5.71 - $6.9 $211,321 - $255,362
37,009
37,009 $0

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.